Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W P Meehan

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
The Journal of Clinical Investigation|October 15, 1996
Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasiaR E Law, W P Meehan, X P Xi, et al.
Basic Research in Cardiology|February 24, 2001
Integrins alphavbeta3 and alphavbeta5 mediate VSMC migration and are elevated during neointima formation in the rat aortaK Kappert, F Blaschke, W P Meehan, et al.
Circulation|December 31, 1997
Myocardial osteopontin expression is associated with left ventricular hypertrophyK Graf, Y S Do, N Ashizawa, et al.
The Journal of Clinical Investigation|November 15, 1996
Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contractionN Ashizawa, K Graf, Y S Do, et al.
Journal of Cardiovascular Pharmacology|November 15, 2001
Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migrationS Goetze, U Kintscher, S Kim, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient miceA R Collins, W P Meehan, U Kintscher, et al.
Circulation|March 22, 2000
Expression and function of PPARgamma in rat and human vascular smooth muscle cellsR E Law, S Goetze, X P Xi, et al.
Journal of Cardiovascular Pharmacology|May 17, 2000
Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cellsS Goetze, S Kim, X P Xi, et al.
The Journal of Clinical Investigation|July 1, 1995
Blood pressure lowering by pioglitazone. Evidence for a direct vascular effectT A Buchanan, W P Meehan, Y Y Jeng, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Journal of Clinical Investigation|October 15, 1996
Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasiaR E Law, W P Meehan, X P Xi, et al.
Basic Research in Cardiology|February 24, 2001
Integrins alphavbeta3 and alphavbeta5 mediate VSMC migration and are elevated during neointima formation in the rat aortaK Kappert, F Blaschke, W P Meehan, et al.
Circulation|December 31, 1997
Myocardial osteopontin expression is associated with left ventricular hypertrophyK Graf, Y S Do, N Ashizawa, et al.
The Journal of Clinical Investigation|November 15, 1996
Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contractionN Ashizawa, K Graf, Y S Do, et al.
Journal of Cardiovascular Pharmacology|November 15, 2001
Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migrationS Goetze, U Kintscher, S Kim, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient miceA R Collins, W P Meehan, U Kintscher, et al.
Circulation|March 22, 2000
Expression and function of PPARgamma in rat and human vascular smooth muscle cellsR E Law, S Goetze, X P Xi, et al.
Journal of Cardiovascular Pharmacology|May 17, 2000
Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cellsS Goetze, S Kim, X P Xi, et al.
The Journal of Clinical Investigation|July 1, 1995
Blood pressure lowering by pioglitazone. Evidence for a direct vascular effectT A Buchanan, W P Meehan, Y Y Jeng, et al.
Pageof 3